FDA Concerned By Shrinking Vaccine Supplier Pool, CBER's Zoon Says

The potential for vaccine manufacturers to exit the business is "very troubling" to FDA, Center for Biologics Evaluation & Research Director Kathryn Zoon, PhD, told the Regulatory Affairs Professionals Society annual meeting in Washington, D.C. Oct. 4.